Abstract
We assess the impact of asymptomatic transmission on epidemic potential of novel respiratory pathogens (like COVID-19) – as measured both by the basic reproduction number (i.e., the expected number of secondary cases generated by an average primary case in a fully susceptible population) and the fraction of new secondary cases attributable to asymptomatic individuals. We show that the impact of asymptomatic transmission depends on generation intervals (i.e., time between when an individual is infected and when that individual infects another person). If the generation-interval distribution of asymptomatic transmission differs from that of symptomatic transmission, then estimates of the basic reproduction number which do not explicitly account for asymptomatic cases may be systematically biased. Specifically, if asymptomatic cases have a shorter generation interval than symptomatic cases, ℛ0 will be over-estimated, and if they have a longer generation interval, ℛ0 will be underestimated. We also show that as the length of asymptomatic generation intervals increase, estimates of the realized proportion of asymptomatic transmission during the exponential phase of the epidemic decrease. Our analysis provides a rationale for assessing the duration of asymptomatic cases of COVID-19 in addition to their prevalence in the population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported, in part, by support from the Army Research Office to JSW (W911NF1910384).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Electronic address: dushoff{at}mcmaster.ca; URL: https://mac-theobio.github.io/dushoff.html
↵† Electronic address: jsweitz{at}gatech.edu; URL: http://ecotheory.biology.gatech.edu
Data Availability
All code is available at https://github.com/mac-theobio/coronavirus_asymptomatic.